Stock IPA IMMUNOPRECISE ANTIBODIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ImmunoPrecise Antibodies Ltd.

Equities

IPA

CA45257F2008

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.32 USD +10.55% Intraday chart for ImmunoPrecise Antibodies Ltd. +4.76% -22.81%
Apr. 22 ImmunoPrecise Antibodies Ltd. Announces an Expansion of Its LENSai Platform CI
Apr. 12 ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With Accelerated Discovery And Delivery Of Treatments CI

Evolution of the average Target Price on ImmunoPrecise Antibodies Ltd.

Price target over the last 5 years

History of analyst recommendation changes

ecdb5768845ad4797.kGGAb42f8ZfTtM3VmU7BP_3IFtyP2e0PPpan7XPxgRU.4zS1J-Pmg8ih3bSw3gWMfa2SZ67DnqN_ec7_lBbFyGbkM9ck0te1rrnhgA~579cdd80011c74dbb9cfde096de6a086

Analyst Recommendations on ImmunoPrecise Antibodies Ltd.

HC Wainwright Starts ImmunoPrecise Antibodies at Buy With CA$12.09 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.32 USD
Average target price
7 USD
Spread / Average Target
+430.30%
High Price Target
9 USD
Spread / Highest target
+581.82%
Low Price Target
5 USD
Spread / Lowest Target
+278.79%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ImmunoPrecise Antibodies Ltd.

HC Wainwright

Ratings for ImmunoPrecise Antibodies Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. IPA Stock
  4. Consensus ImmunoPrecise Antibodies Ltd.